Halozyme Therapeutics Inc’s filing revealed that its PRESIDENT AND CEO Torley Helen unloaded Company’s shares for reported $1.15 million on Jul 10 ’25. In the deal valued at $57.43 per share,20,000 shares were sold. As a result of this transaction, Torley Helen now holds 733,719 shares worth roughly $41.93 million.
Then, Torley Helen sold 20,000 shares, generating $1,128,655 in total proceeds. Upon selling the shares at $56.43, the PRESIDENT AND CEO now owns 733,719 shares.
Before that, Torley Helen sold 20,000 shares. Halozyme Therapeutics Inc shares valued at $1,110,245 were divested by the PRESIDENT AND CEO at a price of $55.51 per share. As a result of the transaction, Torley Helen now holds 733,719 shares, worth roughly $41.93 million.
A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in mid May from “an Overweight” to “an Equal-weight”. Leerink Partners also remained covering HALO and has decreased its forecast on May 13, 2025 with a “an Underperform” recommendation from previously “Market perform” rating. Wells Fargo revised its rating on October 07, 2024. It rated HALO as “an Equal weight” which previously was an “an Overweight”.
Price Performance Review of HALO
On Friday, Halozyme Therapeutics Inc [NASDAQ:HALO] saw its stock fall -0.83% to $57.15. Over the last five days, the stock has gained 5.83%. Halozyme Therapeutics Inc shares have risen nearly 8.07% since the year began. Nevertheless, the stocks have risen 19.54% over the past one year. While a 52-week high of $70.50 was reached on 05/07/25, a 52-week low of $42.01 was recorded on 05/14/25.
Levels Of Support And Resistance For HALO Stock
The 24-hour chart illustrates a support level at 56.67, which if violated will result in even more drops to 56.19. On the upside, there is a resistance level at 57.75. A further resistance level may holdings at 58.34.
How much short interest is there in Halozyme Therapeutics Inc?
A steep rise in short interest was recorded in Halozyme Therapeutics Inc stocks on 2025-06-13, growing by 0.37 million shares to a total of 11.07 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 10.69 million shares. There was a rise of 3.39%, which implies that there is a positive sentiment for the stock.
